Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β −50 T/C SNP
- 7 March 2005
- journal article
- clinical trial
- Published by Elsevier in Neuroscience Letters
- Vol. 376 (1) , 51-55
- https://doi.org/10.1016/j.neulet.2004.11.022
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depressionNeuroscience Letters, 2004
- Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase‐3 protein expression in the mouse suprachiasmatic nucleiEuropean Journal of Neuroscience, 2004
- Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascadeProceedings of the National Academy of Sciences, 2004
- A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorderNeuroscience Letters, 2004
- Search for a common mechanism of mood stabilizersBiochemical Pharmacology, 2003
- A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19Molecular Psychiatry, 2002
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingPublished by Elsevier ,2001
- Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effectBiological Psychiatry, 2001
- Early onset of lithium prophylaxis as a predictor of good long-term outcomeArchiv Fur Psychiatrie Und Nervenkrankheiten, 1999
- Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDMDiabetologia, 1997